Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
Conditions: Schizophrenia; Schizoaffective Disorder Interventions: Drug: Memantine; Drug: Placebo Sponsor: University of California, San Diego Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials
Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases
Condition: Metastatic Malignant Neoplasm to Brain Interventions: Radiation: Conformal Whole Brain Radiotherapy with Unilateral Hippocampal Avoidance; Radiation: Conformal Whole Brain Radiotherapy with Bilateral Hippocampal Avoidance; Drug: Memantine Hydrochloride Sponsor: National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2021 Category: Research Source Type: clinical trials